FdaApplication
BLA 125874
Identifiers
- fda_app_no: BLA125874
Properties
| Property | Value |
|---|---|
| applicant_name | Regeneron Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2026-04-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OTARMENI | — | 3x10^13VG/ML | Suspension |
1 product